Hyperinsulinemia along with hyperandrogenemia and enhanced levels of IGF-1 inhibit sex hormone-binding globulin secretion, which surges the levels of bioactive androgens and worsens the clinical manifestations of androgen excess in PCOS patients (29). This evidence concerns the gene IGF1 and polycystic ovary syndrome.